Zobrazeno 1 - 9
of 9
pro vyhledávání: '"PoChung Jordan Chou"'
Autor:
PoChung Jordan Chou, Peter, Rebecca Mary, Shannar, Ahmad, Yuxin Pan, Dave, Parv Dushyant, Jiawei Xu, Sarwar, Md Shahid, Ah-Ng Kong
Publikováno v:
Cancer Journal; Sep/Oct2024, Vol. 30 Issue 5, p320-328, 9p
Autor:
Pochung Jordan Chou, Md Shahid Sarwar, Lujing Wang, Renyi Wu, Shanyi Li, Rasika R. Hudlikar, Yujue Wang, Xiaoyang Su, Ah-Ng Kong
Publikováno v:
Cancer Prevention Research. 16:321-332
Suberoylanilide hydroxamic acid (SAHA) is a histone deacetylase (HDAC) inhibitor with anticancer effects via epigenetic and non-epigenetic mechanisms. The role of SAHA in metabolic rewiring and epigenomic reprogramming to inhibit pro-tumorigenic casc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66338b13c06168235b61f2a67796ff4e
https://doi.org/10.1158/1940-6207.capr-22-0384
https://doi.org/10.1158/1940-6207.capr-22-0384
Autor:
Ah-Ng Kong, Xiaoyang Su, Yujue Wang, Rasika R. Hudlikar, Shanyi Li, Renyi Wu, Lujing Wang, Md Shahid Sarwar, Pochung Jordan Chou
Supplementary Table S1 shows the primer sequences of the genes used in the qPCR assay.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7415889a2125d6084bbff69c1d2c87cb
https://doi.org/10.1158/1940-6207.22552131
https://doi.org/10.1158/1940-6207.22552131
Autor:
Ah-Ng Kong, Xiaoyang Su, Yujue Wang, Rasika R. Hudlikar, Shanyi Li, Renyi Wu, Lujing Wang, Md Shahid Sarwar, Pochung Jordan Chou
Supplementary Fig. S2 shows the changes in metabolic profile after suberoylanilide hydroxamic acid (SAHA) treatment for 3 and 24 h.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::947cbd8a68b5dc51de0a1a8e5b15b83d
https://doi.org/10.1158/1940-6207.22552137.v1
https://doi.org/10.1158/1940-6207.22552137.v1
Autor:
Ah-Ng Kong, Xiaoyang Su, Yujue Wang, Rasika R. Hudlikar, Shanyi Li, Renyi Wu, Lujing Wang, Md Shahid Sarwar, Pochung Jordan Chou
Suberoylanilide hydroxamic acid (SAHA) is a histone deacetylase (HDAC) inhibitor with anticancer effects via epigenetic and non-epigenetic mechanisms. The role of SAHA in metabolic rewiring and epigenomic reprogramming to inhibit pro-tumorigenic casc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17b8be8e1b3b238cf4ed0c28f54a0c8a
https://doi.org/10.1158/1940-6207.c.6489513
https://doi.org/10.1158/1940-6207.c.6489513
Autor:
Shanyi Li, Pochung Jordan Chou, Rasika Hudlikar, Ah-Ng Tony Kong, Lujing Wang, Renyi Wu, Rebecca Peter, Ahmad Shannar, Zhigang Liu, Hsiao-Chen Dina Kuo
Publikováno v:
Free Radical Biology and Medicine. 179:328-336
Biological redox signaling plays an important role in many diseases. Redox signaling involves reductive and oxidative mechanisms. Oxidative stress occurs when reductive mechanism overwhelms oxidative challenges. Cellular oxidative stress occurs when
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::006cc5388b94ed097b7de6279cb7803e
https://doi.org/10.1016/j.freeradbiomed.2020.12.007
https://doi.org/10.1016/j.freeradbiomed.2020.12.007
Autor:
Rasika R. Hudlikar, Pochung Jordan Chou, Hsiao-Chen Dina Kuo, Davit Sargsyan, Renyi Wu, Ah-Ng Kong
Publikováno v:
Food and Chemical Toxicology. 174:113656
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ff89c4ffe0c6c89402b8f490a1d859a
https://doi.org/10.1016/j.fct.2023.113656
https://doi.org/10.1016/j.fct.2023.113656
Autor:
Pochung Jordan Chou, Ahmad Shannar, Zhigang Liu, Rasika Hudlikar, Lujing Wang, Hsiao-Chen Dina Kuo, Xia Liu, Ah-Ng Tony Kong, Rebecca Peter, Renyi Wu, Shanyi Li
Publikováno v:
Cancer Prev Res (Phila)
Cancer is a complex disease and cancer development takes 10–50 years involving epigenetics. Evidence suggests that approximately 80% of human cancers are linked to environmental factors impinging upon genetics/epigenetics. Because advanced metastas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae4c7aa6574ced1979e08b57c11ac4bd
https://doi.org/10.1158/1940-6207.capr-20-0217
https://doi.org/10.1158/1940-6207.capr-20-0217
Autor:
Ah-Ng Tony Kong, Pochung Jordan Chou, George J. Poiani, Zhigang Liu, Ahmad Shannar, Shanyi Li, Lujing Wang, Hsiao-Chen Dina Kuo, Renyi Wu, Louis F. Amorosa, Rebecca Peter, Luigi Brunetti, Xia Liu, Rasika Hudlikar
Publikováno v:
Current Pharmacology Reports
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented challenges to the healthcare systems in almost every country around the world. Currently, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a8e93bb849eb8f8140b300c37b05353
https://doi.org/10.1007/s40495-020-00216-7
https://doi.org/10.1007/s40495-020-00216-7